glutamic acid and msh, 4-nle-7-phe-alpha-
glutamic acid has been researched along with msh, 4-nle-7-phe-alpha- in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Deenen, R; Faber, C; Herrmann, AM; Klotz, L; Köhrer, K; Limmer, A; Loser, K; Luger, TA; Meuth, SG; Mykicki, N; Schwab, N; Sparwasser, T; Wachsmuth, L; Wiendl, H | 1 |
Other Studies
1 other study(ies) available for glutamic acid and msh, 4-nle-7-phe-alpha-
Article | Year |
---|---|
Melanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease.
Topics: Action Potentials; alpha-MSH; Animals; Blood-Brain Barrier; Bone Marrow Cells; Cell Proliferation; Central Nervous System; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Flow Cytometry; Gene Expression Profiling; Glutamic Acid; Hippocampus; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Protein Binding; Receptor, Melanocortin, Type 1; T-Lymphocytes, Regulatory | 2016 |